Evidence map›Paper›PMID 32956364›Full record

ArticlePloS one2020

Stroke in the adult Qatari population (Q-stroke) a hospital-based retrospective cohort study.

Yahia Z Imam, Saadat Kamran, Maher Saqqur, Faisal Ibrahim, Prem Chandra, Jon D Perkins, Rayaz A Malik, Naveed Akhtar, Salman Al-Jerdi, Dirk Deleu and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Translating and piloting a cardiovascular risk assessment and management online tool using mobile technology.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Yahia Z ImamNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0003-4623-733X
Saadat KamranNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Maher SaqqurNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Faisal IbrahimNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-6424-8994
Prem ChandraMedical Research Center, Hamad Medical Corporation, Doha, Qatar.
Jon D PerkinsNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Rayaz A MalikWeill Cornell Medicine-Qatar, Doha, Qatar.
Naveed AkhtarNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Salman Al-JerdiWeill Cornell Medicine-Qatar, Doha, Qatar.
Dirk DeleuNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Osama ElalamyNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Yasir OsmanNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Gayane MalikyanNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Hisham ElkhiderNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Suha ElmakkiNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Lubna ElSheikhNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Noha MhjobNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Mohamed S AbdelmoneimNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-5073-6532
Nima AlkhawadNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Ahmed OwnNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Ashfaq ShuaibDivision of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.
Hamad Medical Corporation · QAWeill Cornell Medical College in Qatar · QAUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies assessing the burden of stroke in Qataris are limited. We aim to study stroke in the Qatari population.

methodsA retrospective review was undertaken of all Qatari adults presenting with stroke to Hamad Medical Corporation over a 5-year period. Descriptive statistics were used to summarize demographic and all other clinical characteristics of the patients. The primary outcome was the incidence of stroke in the Qatari patients. Comparison was made between the sexes.

results862 patients were included, with 58.9% being male. The average incidence of stroke over the 5-year period was 92.04 per 100,000 adult Qatari population. The mean age of the cohort was 64.3±14.4 years, (range 19-105 years). The mean age of first ever cerebrovascular event was 63.2±14.5 years. The diagnosis was ischemic stroke in (73.7%), transient ischemic attack in (13.8%), intracerebral hemorrhage (ICH) in (11.6%), subarachnoid hemorrhage in (0.7%) and (0.2%) cerebral venous sinus thrombosis. Small vessel disease was the most common cause of ischemic stroke accounting for (46.5%), followed by large artery atherosclerosis (24.5%). Hypertension (82.7%) and diabetes (71.6%) were particularly prevalent in this cohort. Females were older (65.8±14.1 vs 63.4±14.5 years), had more hypertension and diabetes and more disability or death at 90 days (p<0.05) compared to Qatari males.

conclusionStroke occurs at a significantly lower age in Qataris compared to the western population. This study has uncovered sex differences that need to be studied further.

Indexed as

AdultAgedAged, 80 and overFemaleHospitalsHumansIncidenceMaleMiddle AgedQatarRegistriesRetrospective StudiesRisk FactorsStrokeYoung Adult

Identifiers

PMID32956364
PMCPMC7505434
OpenAlexW3087590821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.